Sign In
Section Navigation
Common TitlePRINCE-1
Official Title A Prospective Single Arm, Open-label, International, Multicenter Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Atazanavir (ATV) Powder Boosted With Ritonavir (RTV) With an Optimized NRTI Background Therapy, in HIV Infected Pediatric Patients Greater Than or Equal to 3 Months to Less Than 6 Years. (Pediatric Atazanavir International Clinical Evaluation: the PRINCE I Study)
Phase Phase III
ClinicalTrials.gov NCT01099579
Treatments
Atazanavir
Atazanavir Reyataz

Atazanavir

Tradename:ReyatazOther Names:ATVClass:Protease Inhibitors (PI)
Categories PediatricsTreatment-NaiveTreatment-Experienced
Funding
IndustryBristol-Myers Squibb
References
  • Strehlau R, Donati AP, Arce PM, et al. PRINCE-1: safety and efficacy of atazanavir powder and ritonavir liquid in HIV-1-infected antiretroviral-naïve and -experienced infants and children aged ≥3 months to <6 years. J Int AIDS Soc. 2015;18:19467.
    [PubMed Abstract]

Share by e-mail

Since you've received 80% or better on this quiz, you may claim continuing education credit.

You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.